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ABSTRACT 
 
ABU-JEISH, ABDEL-HADI, RUSHDI, Masters: January: 2019, Master of Public Health 
Title: FACTORS AFFECTING DOSE OF CARDIAC REHABILITATION AROUND 
THE GLOBE. 
Supervisor of Thesis: Dr. Karam Turk-Adawi and Dr. Mohammed Fasihul Alam. 
 
Background: Cardiac Rehabilitation (CR) program promotes secondary prevention of 
cardiovascular disease. It is well-established that there is a dose-response association 
between CR participation and health outcomes. However, programs around the world are 
of varying durations, and sessions are offered at varying frequencies in each program.  
Objective: The aims of this study are to describe CR dose by country, World Health 
Organization’s (WHO) region, country income classification and global levels; and to 
determine factors that could affect the dose of CR worldwide. 
Method: This is a cross sectional study based on secondary data collected using Cardiac 
Rehabilitation Program Questionnaire developed by the International Council of 
Cardiovascular Prevention and Rehabilitation (ICCPR). Analyses included descriptive 
frequencies for the dose.  A generalized linear model (GLM) used by applying 
generalized estimating equations to compare the dose among WHO regions and among 
income country groups, and to identify program -related factors (location of the program, 
payment, location of the program within hospital, presence of cardiologist, number of 
patients served in each session, presence of other program within 20 km, presence of any 
  
   
iv 
 
alternative models, funding of program) and patient related factors (type of diagnosis, 
level of risk) that might affect the dose of the CR program.  
Results: There was a significant difference between the six WHO regions (p-value 
<0.05), Americas had the largest dose with a mean of 3263.0  ± 2631.4 minutes, and 
South-East Asia had the smallest dose with a mean of 871 ± 542.3 minutes.  The 
difference in the dose among the country -income groups was not significant (p-value 
0.34). The following factors, among others, were positively associated with dose (p-value 
< 0.05): presence of cardiologist on the CR team (multiplicative effect on the mean 
[MEM], 1.29; 95% CI: 1.06 to 1.57), funding the CR program by a combination of 
governmental organizations and private health insurance (MEM, 1.27; 95% CI: 1.03 to 
1.57), number of staff in the CR team (MEM: 1.17, 95% CI: 1.01 to 1.36), number of 
patients per session (MEM: 1.03, 95% CI: 1.01 to 1.04), and location of CR program 
(MEM:1.35, 95% CI:1.01 to 1.804). 
Conclusion: Both patient-related factors and organizational factors have key roles in 
doses of CR program. Findings of this study have important implications for the directors 
of CR program. These findings could guide decision-makers towards improving the dose 
of CR programs to achieve reductions in both mortality and morbidity associated with 
cardiovascular diseases. 
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  الدراسة ملخص
  
 ومن. الدموية والأوعية القلب أمراض من الثانوية الوقاية يعزز  القلب مرضى تأهيل إعادة برنامج ان: المقدمة
 من الصحية والنتائج التأهيل اعادة برنامج في القلب مريض لها يخضع التي الجرعة بين علاقة هناك أن المعروف
 لمرضى مختلفة جرعات تقدم العالم أنحاء جميع في القلب لامراض التأهيل برامج فإن ، ذلك ومع. البرنامج هذا
 القلب.
 حسب و البلد حسب القلب لمرضى التأهيل برامج جرعة وصف إلى الدراسة هذه تهدف  :للدراسة الرئيسي الهدف
 العوامل تحديد الى الدراسة وتهدف. العالم حول للدول الاقنصادي التصنيف حسب و العالمية الصحة منظمة أقاليم
  العالم. أنحاء جميع في القلب لمرضى التأهيل اعادة برامج جرعة على تؤثر أن يمكن التي
 
 طوره الذي القلب لمرضى  التأهيل برنامج استبيان باستخدام جمعها تم  معلومات على تعتمد  :الدراسة منهج
 يتضمن البيانات تحليل.  الدموية الأوعية و القلب لمرضى التأهيل وإعادة القلب أمراض من للوقاية الدولي المجلس
  raenil dezilareneG( الاحصائي النموذج باستخدام البينات تحليل وتم. التأهيل برامج لجرعة وصفية تكرارات
 مجموعات وبين العالمية الصحة منظمة أقاليم بين الجرعة تقديرية لمقارنة معادلات تطبيق طريق  عن  ledom(
 وهي البرنامج جرعة على تؤثر قد التي بالبرنامج المرتبطة العوامل ولتحديد ، الاقتصادي التصنيف حسب البلدان
 ، لا أم المستشفى داخل البرنامج يقع هل و ، للبرنامج المالية والموارد ، التأهيل اعادة لبرنامج الجغرافي موقع(
 مسافة ضمن آخر برنامج وجود ، جلسة كل في تدريبهم تم الذين المرضى عدد ، البرنامج في القلب طبيب ووجود
 القلب). مريض لدى الخطورة مستوى ، للمريض الطبي التشخيص ، المنطقة في بديلة برامج أي وجود ، كم 02
 
 مةظمن طقمنان بي القلب لمرضى التأهيل برامج جرعة في رکبي فختلاا كناه ان الدراسة أثبتت :الدراسة جنتائ
 رلأکبا عةرلجا كتمتل الجنوبية وأمريكا الشمالية أمريكا تکانو ،)50.0< eulav-p( تة لسا لعالميةا لصحةا
 أثبتت و. للبرنامج ةساع 51 مع الأقل الجرعة تمتلك أسيا رقش وبجن نتکاو للبرنامج، ساعة 45 طسوبمت
 العوامل أن الدراسة وأثبتت.  الاقتصادي الدخل حسب المصنفة المناطق بين الجرعة في فرق لايوجد انه الدراسة
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 ، التاهيل اعادة برامج فريق ضمن  القلب طبيب وجود: هي و ايجابي بشكل التأهيل برامج بجرعة ترتبط التالية
 في الموظفين عدد ، معا   الخاص الصحي والتأمين الحكومية المنظمات  خلال من التأهيل اعادة برنامج تمويل
 المناطق في التأهيل برنامج وموقع ، التأهيل برامج من جلسة كل في المرضى عدد ، الـتأهيل برنامج فريق
 الريفية.
 أدوار لها القلب لمرضى التأهيل برامج بجرعة ارتباطها الدراسة هذه أثبتت التي العوامل ان:  الدراسة من الاستنتاج
 جرعات لتحسين التأهيل برامج مدراء توجه قد النتائج هذه. القلب لمرضى الـتأهيل برامج تحسين في ومهمة رئيسية
  الدموية. والأوعية القلب لمرضى أفضل صحية تنائج لتحقيق التأهيل برامج
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CHAPTER 1: INTRODUCTION 
Cardiovascular disease (CVD) is the first cause of  death worldwide (1). In 2015, 
17.7 million people died due to CVD, of which 6.7 million deaths are due to stroke and 
7.4 million deaths are due to coronary heart disease. CVD’s deaths contribute to 31% of 
all deaths worldwide and to 10% of the global burden of disease (1). About 80% of 
deaths of CVD happen in low and  middle-income countries (LMICs) (1).  
Cardiac rehabilitation (CR) program promotes secondary prevention of CVD, it is 
an essential health care for individuals with cardio-vascular disease (2). In 1993, the 
World Health Organization (WHO) defines CR as “a group of activities with the 
collaboration of multidisciplinary team of health professionals are required to affect the 
underlying cause of cardiovascular disease to maintain the patients’ best mental, physical, 
and social conditions, so they will be able to preserve and continue their places as usual 
as possible in the life of their surrounding community”. CR  consists of social, physical, 
and psychological interventions that promote a healthy and active lifestyle (2). 
Specifically, CR consists of the following core components: initial assessment of patient, 
i.e. medical history, family history of CVD, behavioral risk factors (sedentary life, 
smoking, unhealthy food), assessment of clinical risk factors including hypertension, 
lipids in blood, obesity, and depression; risk factor management (e.g., smoking, 
hypertension, sedentary life, obesity, high levels of glucose and lipids (cholesterol, 
triglycerides, and low-density lipoprotein); structured exercise; patient education; and 
psychosocial counseling (2). CR is evidence-based program designed to address the 
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health needs of patients diagnosed with acute coronary syndrome, heart valve surgery, 
coronary artery surgery or percutaneous coronary intervention (3).  
 Cardiac rehabilitation program improves quality of life, reduces morbidity and 
mortality via reduced cardiovascular disease symptoms; improved exercise tolerance;  
improved cardiac function; maintained activities of daily living and decreased levels of 
depression, stress, and anxiety (3). A recent systematic review showed that CR reduces 
CVD mortality by 25% and hospital readmissions by 18 % (4). Structured supervised 
exercise is central to the success of CR program for patients who have acute coronary 
syndrome, coronary revascularization, patients who have undergone heart transplant or 
heart valve surgery, in addition to patients with chronic heart failure (2).   
However, CR is underutilized globally, with only 38.8% of countries 
implementing this beneficial program(5). This global problem has triggered the 
International Council of Cardiovascular Prevention and Rehabilitation (ICCPR), a non-
profit organization dedicated to promote CVD prevention and cardiac rehabilitation, to 
conduct a global survey in 2016 characterizing cardiac rehabilitation programs and gaps 
in the services around the globe. The present study is based on secondary data collected 
by the ICCPR.   
It is well-established that there is a dose-response association between CR 
participation and health outcomes (6). However, programs around the world are of 
varying durations, and sessions are offered at varying frequencies (7). Therefore, the 
main goal of this study is to describe the dose of cardiac rehabilitation (CR) programs 
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offered worldwide, and identify the factors that could affect the dose of CR globally. 
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CHAPTER 2: LITERATURE REVIEW 
 
The literature review is divided into nine separated sections, the first section is 
about cardiovascular diseases, its burden and prevalence in the world, second section  
addresses risk factors of CVD with a focus on physical inactivity as a risk factor,  third  
section  focuses on the relationship between physical activity and CVD, fourth  section  
explains the recommended level of physical activity for CVD’s patient to achieve the 
outcomes, fifth  section is an introduction about cardiac rehabilitation program, sixth 
section  explains the component of CR program, seventh section  explains the phases of 
CR program, the eighth section  focuses on the benefits of participation on CR program 
and finally the last section  focuses on the variation in the number of sessions offered in 
CR programs worldwide and the factors that could affect the dose of CR programs.  
Cardiovascular Disease, Burden and Prevalence: 
CVD is a group of abnormal conditions that affect body vessels (vascular) and 
heart (cardio) (8). CVD includes abnormal conditions in the function and/or structure of 
the heart (i.e. cardiomyopathy, rheumatic heart disease and heart failure) or abnormal 
condition of the blood vessels such as: coronary heart disease (CHD) and peripheral 
vascular disease (8). 
Cardiovascular Disease is the first cause of death worldwide (1). In 2015, 17.7 
million people died due to CVDs which is equal to 31% of all deaths around the world 
(1). The majority of  these deaths (7.4 million) were due to coronary heart disease, and  
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6.7 million deaths were due to stroke (1). This number is expected to increase 23.6 
million by 2030. Cardiovascular diseases (CVD) continue to be the number one  killer 
worldwide (9).  
Risk Factors of Cardiovascular Disease: 
Several risk factors can increase the risk of CVD (10). Risk factors are classified 
to non-modifiable risk factors and modifiable risk factors. Non-modifiable risk factors 
include age, family history, gender, and race. Males tend to have heart attacks earlier in 
life than females (11). A family history of stroke or coronary heart disease increases the  
risk of CVD  (11). 
The modifiable risk factors include: alcohol, hypertension, physical inactivity, 
hyperlipidemia, overweight, tobacco smoking, and low fruit and vegetable intake (10). 
The two types of diabetes mellitus are also considered as major risk factors, 60% of death 
in diabetic patients is caused by CVD (10). Physical in-activity is considered a major risk 
factor for mortality in the globe and around 5.2 million deaths of all causes in 2008 are 
due to physical in-activity (12). Many studies revealed that high sedentary life style and 
low physical activity levels have an impact on adverse outcomes of health (12), therefore 
the core idea of CR is to raise the level of physical activity among patients with CVD to 
reverse mechanism of disease. 
Cardiovascular Disease and Physical Activity:  
CR program is based on the concept that health outcome is affected by the amount 
or dose of physical activity (7). Dose is determined by multiplying the frequency with the 
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duration (7). Frequency is the number of sessions performed per week multiplied by 
number of weeks in the CR program (2). Duration is the time of each individual session 
of physical activity (2). 
Cardiorespiratory fitness is the capability of the heart and lung to supply oxygen 
to the muscles of the body during physical exercise (13), cardiorespiratory fitness have a 
protective effect because it decreases the risk of morbidity and mortality from CVD (14). 
Persons who are actively engaged in a suggested level of physical activity, at least 150 
minutes  per week of modest to strong exercise (15), have a decreased mortality risk for 
all causes of death (12). However, around 31% of the population in the world does not 
meet the suggested levels of physical activity  (16). 
A study done by Warburton in 2006 showed a proof of a linear association 
between CVD and level of physical activity, as level of physical activity increased the 
risk of CVD decreased (14). As per the World Health Organization (WHO), 85% of 
chronic diseases like CVD can be prevented by healthy diet and regular exercise (15). A 
study  comparing the mortality risk among 242,397 individuals, based on their 
engagement in physical activity, revealed that all-causes of mortality was less by 27%  
for people without any co-morbidities, and less by almost 50% in those with chronic co-
morbidities  who engaged in a suggested level of physical activity (17). 
In order to maintain and promote health, the American Heart Association (AHA) 
and the American College of Sports Medicine (ACSM) encourage all individuals who are 
18 to 65 years to engage in at least 30 minutes of modest intensity of physical activity  
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five days per week or at least of 20 minutes of strong-intensity of physical activity in 
three days per week (18).  
Many studies provided evidence on the association between CVD and physical 
activity. For example, a cohort study included  44,452 professional healthy males,  their 
age ranged from 40 to 75 years and they were followed for 12 years at 2-year intervals, 
revealed that increasing level of physical activity resulted in decreasing level of risk of 
CHD in a dose-response relationship (19). The similar dose-response relationship 
between CVD and physical activity risk was also found in Haskell et al (18). 
Recommended Level of Physical Exercise for Patients with Cardiovascular Disease:  
 
The recommended levels of physical activity by American College of Cardiology 
and American Heart Association for patients with cardiovascular disease are as 
following: 
• Assess the patient risk with exercise by history and exercise test to help for 
determine the suitable level of physical activity (20). 
• All patients are encouraged to engage in modest intensity of physical activity for 
30-60 minutes per day, for example: brisk walking for five days per week (20). 
• Patients with low risk for adverse event are encouraged to engage in resistance 
training sessions 2 times per week (20). 
• Patients with high-risk are encouraged to participate in medically supervised 
program (e.g. recent myocardial infarction or revascularization) (20).  
• Patients with CVD are encouraged to participate in cardiac rehabilitation program 
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in order to improve their levels of physical activity (20). 
 
Cardiac Rehabilitation: 
Cardiac rehabilitation is based on the advantages of physical activity in reducing 
the risk of CVD. In 1930, patients with acute coronary conditions were encouraged to be 
bed rest for 6 weeks (21). In the early 1950, a short walk for 3 to 5 minutes per day was 
encouraged for 4 weeks after the acute coronary condition, then it was noticed that early 
ambulation did not increase risk of coronary conditions but it prevent many 
complications of bed rest (21).  
In 1968, a published study showed strong evidence for the benefits of early 
exercise and the adverse effect of bed rest for long time (21). The establishment of the 
physiologic basis of the benefits from exercise by many researchers, result in the 
development of Cardiac rehabilitation program to help cardiovascular patients optimize 
and recover their functional status (21). 
In 1993, the World Health Organization (WHO) defines CR as “a group of 
activities with the collaboration of multidisciplinary team of health professionals are 
required to affect the underlying cause of cardiovascular disease to maintain the patients’ 
best mental, physical, and social conditions, so they will be able to preserve and continue 
their places as usual as possible in the life of their surrounding community” (22). 
CR promotes secondary prevention of CVD and it is the essential core component 
of care for all individuals with CVD (2). CR is designed mainly to patients who 
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developed an acute coronary syndrome, heart valve surgery, coronary artery surgery or 
percutaneous coronary intervention (3). It consists of physical, social and psychological 
interventions that promote a healthy and active lifestyle (2). Several systematic reviews 
showed that CR is a cost-effective model of care  (23) that reduces CV mortality by up to 
25% and hospital readmissions by about 18% (4), (24), (25), (26), (27), (28).  
CR achieves these benefits through its’ core components, which are 
internationally agreed,  namely initial assessment, risk factor management (e.g., diet, 
smoking, hypertension, physical activity), structured exercise, patient education, and 
psychosocial counseling (2).  
Structured supervised exercise has been identified as being a core to the success 
of cardiac rehabilitation for individuals with acute coronary syndrome, revascularization 
of coronary arteries, patients who have undergone heart transplant or heart valve surgery, 
in addition to patients with chronic heart failure (2). 
Core Components of Cardiac Rehabilitation Program: 
As per the American Heart Association and the American Association of 
Cardiovascular and Pulmonary Rehabilitation, cardiac rehabilitation program includes the 
following core components: 
• Patient Assessment: Medical History, complete physical Examination, obtains 
resting 12-lead electrocardiogram (ECG)(2). 
• Nutritional Counseling: obtain dietary contents and calculate an estimation of 
total calorie intake per day, assess eating habits and alcohol consumption, and 
  
   
10 
 
prescribe specific dietary modifications (2). 
• Weight Management: measure waist circumference, height and weight. Obtain the 
body mass index (BMI). Develop program that includes intervention for physical 
activity and diet to maintain ideal weight or to reduce over weight (2). 
• Blood Pressure Management: measure blood pressure while resting on two 
different visits and assesses current treatment and compliance. Encourage for 
changes in lifestyle such as smoking cessation, sodium intake restriction, weight 
management, and regular physical exercise (2). 
• Cholesterol Management: obtain complete lipid profile after fasting for 8 to 12 
hours. Assess the treatment of the patient and his compliance. Provide advice for 
diet modification consistent with the current treatment (2). 
• Diabetes Management: test blood sugar level before and after each exercise. 
Obtain fasting blood glucose and glycosylated hemoglobin (HbA1c). Avoid 
physical exercise at peak insulin times. Educate staff and patient about signs of 
hypoglycemia and how to provide appropriate interventions (2). 
• Tobacco Cessation: assess the patient’s status of smoking and if he or she use 
other tobacco products. Specify how many cigarettes per day and duration of 
smoking. Develop and implement plan for smoking cessation (2). 
• Psychosocial Management: assess for symptoms of psychological distress such as 
social isolation, anxiety, depression, anger, and drug abuse. Offer individual and 
small group counseling on stress management and lifestyle changes (2).  
• Physical Activity Counseling: assess current status of physical activity relevant to 
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gender, age and daily life, such as sports, household tasks, driving, and gardening.  
Provide counseling about the needs of physical activity. Modified exercise 
program to meet the need of individual. Encourage patients to engage on 30-60 
minutes per day of mild to moderate intensity physical exercise for five days per 
week (2).  
• Exercise Training: perform symptom-limited exercise testing before participation 
in any exercise. Testing parameters should include assessment of signs and 
symptoms, blood pressure, heart rate, ST-segment changes in the 12-lead 
electrocardiogram (ECG), capacity of exercise and perceived exertion. Classify 
the patient according to the level of risk to determine the required level of for the 
exercise training program. Follow risk stratification system as recommended by 
the American Association of Cardiovascular And Pulmonary Rehabilitation and 
the American Heart Association (2). Based on the findings of the evaluation and 
risk classification of patients, a modified exercise prescription of aerobic and 
resistance training. The modified exercise program should be evaluated by 
referring physician or the program medical director. The exercise prescription 
should include duration modalities, duration, frequency, intensity and progression 
(2). For aerobic exercise: duration (20-60 minutes), frequency (3 to 5 days/week); 
intensity (50-80%) of capacity of the exercise; and modalities: walking, stair 
climbing, treadmill, and cycling (2). For resistance training: frequency (2 to 3 
days/week); intensity of 10-15 repetitions per set to moderate fatigue; duration (1-
3 sets of different lower and upper body exercises); and modalities, weight 
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machines, dumbbells, elastic bands, and free weights (2). Modify the prescription 
of exercise according to the changes of the clinical status.  Exercise includes 
flexibility exercises, warm-up, and cool-down, in each exercise session (2).  
Phases of Cardiac Rehabilitation: 
 
There are four phases for CR program:  
• Phase I: starts in the hospital immediately after a cardiac event. A member of CR 
team provides the patient and his family with information regarding the disease, 
risk factors, medications and social issues. Also, they discuss the importance of 
lifestyle changes and the appropriate level of activity for the patient (29). 
• Phase II: starts 4-6 weeks after discharge of patient from the hospital. The main 
goal is to help  patients to comply with the lifestyle changes recommended in 
Phase I (29). 
• Phase III: consists of 6-12 weeks supervised exercise classes and education about 
cardiac anatomy and physiology; symptom management; medication, stress 
management, risk factors management, behavior modifications, smoking 
cessation, healthy diet, physical activity, daily living activities; and sexual 
activity. Before starting Phase III program, patients will be examined by stress 
test for exercise to determine the capacity for exercise. The main area of interest 
in this research study is the dose of phase III with a focus on exercise during 
cardiac rehabilitation program (29). 
• Phase IV: The main goal is to help patient to maintain the recommended changes 
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in the life style implemented in the previous three phases (29). 
Benefits of Participation in Cardiac Rehabilitation: 
Participation in cardiac rehabilitation program has many clinical, psychological, 
and behavioral outcomes, i.e. prevents recurrence of disease, relieves symptoms, 
improves cardiac function, decreases level of anxiety and depression; promotes 
management of stress, increases compliance with physical activity and ceases smoking. 
In addition, participation in CR program improves quality of life, and reduces morbidity 
and mortality. 
A study done by Sharif (2012) showed that participation in cardiac rehabilitation 
program resulted in improvement in the physical level and decrease level of depression 
after 2 months from coronary artery bypass grafting surgery (30). Further, mortality rates 
from myocardial infarction have significantly decreased after participation in CR 
program  (23-27, 30). Systematic reviews and meta- analysis showed a significant 
reduction in all-cause mortality by 13%-26%, cardiac mortality by 20%- 36%, 
myocardial re-infarction by 25%-47% (23-27). In many studies, improved quality of Life 
was documented as a result of participation in cardiac rehabilitation programs (32) (33). 
For example, a systematic review carried out to identify the efficiency of cardiac 
rehabilitation on health related quality of life (HRQOL), morbidity, and mortality of 
individuals with coronary heart disease (25). The review was carried out by the Cochrane 
Collaboration, which searched for seven databases (using The Cochrane Library Issue 4, 
2009), EMBASE (1980 - December 2009), CINAHL (1982 - December 2009), Expanded 
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Science Citation Index (1900 - December 2009) in addition to MEDLINE (1950 - 
December 2009). Results showed a reduction by 13% in mortality among participants 
with cardiovascular condition who have medium to long period of follow up in cardiac 
rehabilitation (≥ 12 months) and reduction in hospital readmissions by 31% in short 
period of follow up in cardiac rehabilitation (< 12 months). From ten studies measuring 
the HRQOL, seven studies showed greater level of HRQOL after participation in CR 
compared to normal care groups (25).. 
Many studies showed that participation in cardiac rehabilitation led to 
improvement in the level of exercise tolerance and physical activity, improvement in 
blood lipid level, reduction in symptoms, decreased rate of cigarette smoking, 
improvement of stress management and psychosocial well-being, decreased rates of 
recurrence cardiac events, reduction of the atherosclerotic process, reduction in 
hospitalization, readmission and in the mortality and morbidity (3), (26), (34). 
Number of CR Sessions: 
The optimal number of sessions to achieve the benefits outlined above is not 
known, though some national guidelines recommend a minimum number of sessions (6). 
Still, it is well-established that there is a strong dose-response association between 
cardiac rehabilitation sessions and long term outcome, and lower risk for mortality and 
myocardial infarction (6). Comprehensive cardiac rehabilitation programs around the 
world are of varying durations, and sessions are offered at varying frequencies (35). For 
example, in a recent meta-analysis the recommended duration ranged from a minimum of 
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3 weeks in Germany (although this is often residential) to a maximum of 12 months in 
Austria (7). The frequency recommended by the American Association of Pulmonary and 
Cardiovascular Rehabilitation, as well as the European and Canadian Associations for 
Cardiovascular Rehabilitation and Prevention is a minimum of 3 sessions per week, 
whereas guidelines for Austria, Australia, Japan and the United Kingdom recommend 3 
or fewer per week (7).  
 It appears that the total number of sessions in CR program  is generally based on 
reimbursement policies (36) funding requirements and past practice (35). A number of 
studies in the literature found that the more CR sessions patients receive, the better their 
outcomes (37)(38)(6). A meta-analysis showed  that patients exposed to longer CR 
duration, i.e. 3 or more months, had significantly lower CVD mortality by 36% and lower 
risk of recurrent myocardial infarction by 47% (24). A recent meta-analysis 
recommended a minimum of 12 sessions to reduce mortality and 36 sessions to reduce 
percutaneous coronary interventions among patients with coronary heart diseases (6). 
In a systematic review and meta-analysis of the effect of cardiac rehabilitation 
dose on mortality and morbidity, it is demonstrated that  a standard dose of 3 sessions / 
week over 12 weeks (i.e., 36 sessions),in the United States, is associated with  reduction 
in risk of morbidity and mortality from CVD (7).  
On the other hand in the United Kingdom where the dose is much lower at around 
10 sessions, a multi-center randomized controlled trial in representative hospitals, in 
England and Wales, compared 1813 patients referred to comprehensive cardiac 
rehabilitation programs with those with ‘standard care’ (medication without referral to 
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cardiac rehabilitation) reported a lack of benefit (39). Programs generally use higher dose 
in North America than in Europe (7).  
Findings from a number of  studies suggest that CR as delivered in the United 
States (i.e., 36 sessions) (7) and Ontario, Canada (i.e., 40 sessions) (7) is sufficient to 
achieve the reduction in mortality and morbidity if patients adhere to their prescribed 
program (4). However, CR as delivered in parts of Europe and the United Kingdom may 
not be sufficiently intense (39). It is well established that the minimum duration of CR in 
the United Kingdom is 8 weeks (frequency is not specified)(39).  
There is lack of studies on the recommended minimum dose of a CR program in 
terms of minutes. To the best of our knowledge, there is only one study that provided a 
minimum dose of CR programs and in specific diagnosis. This is a Cochrane systematic 
reviews, which showed that patients who had 1000 or more minutes had significantly 
lower CVD mortality of 25% and myocardial infarction (MI) of 26% (4). To the best of 
our knowledge, there are no evidence based recommendations on what dose should be 
offered to patients to achieve optimal clinical outcome. This variation significantly 
affects costs to deliver CR, capacity to serve patients, and outcomes achieved. Results 
also suggested that duration or frequency of sessions by themselves did not impact 
outcomes, but total dose was what mattered (7). Still, there is no study that describes and 
characterizes doses of CR globally. Additionally, there is lack of data on factors affecting 
CR dose. These factors can be either organizational (factors related to the program itself) 
or patient’s factors (factors related to patient, e.g. diagnosis and level of risk). This 
variation in the dose of CR delivered significantly affects the clinical outcomes.  
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CHAPTER 3: RESEARCH QUESTIONS, HYPOTHESES, AND 
OBJECTIVES 
 
Research Questions: 
 
The main research questions of this study are:  
1) What is the current dose of CR at country, WHO-region and global levels? 
2) What are the potential factors that could affect CR dose globally? 
Research Hypothesis: 
 
The dose of Cardiac Rehabilitation program (number of sessions of exercise 
offered per week multiplied by number of weeks per program, multiplied by number of 
minutes per session) is associated with factors related to the CR program and with factors 
related to the patient. 
      Sub-hypotheses: 
 
• The dose of cardiac rehabilitation program is positively associated with 
governmental funding of cardiac rehabilitation program. 
• The dose of cardiac rehabilitation program is negatively associated with patient’s 
level of risk, i.e patients with higher risk of developing another cardiac event  
have lower doses. 
• The dose of cardiac rehabilitation program is positively associated with the  
number of staff in the CR team. 
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Theoretical Framework & Conceptual Framework: 
 
      Theoretical Framework: 
 Our  study used the Andersen framework (40) as a conceptual framework to 
identify the factors that could affect the dose of cardiac rehabilitation program.  The 
Anderson model was used by many investigators to investigate utilization of health care 
services. The model was developed in the 1960s, and since it has gone through four 
phases (40).  The purpose of this model is to identify factors that either facilitate or 
inhibit utilization of health care services.  The framework consists of four components: 
environmental factors, population characteristics, individual’s health behavior, and health 
outcomes (Figure 1).  According to this model, environmental factors affect the 
individual characteristics both directly and indirectly through the health care system.  
 Inclusion of the health care system emphasizes the importance of organization, 
health care policy and resources in the health care system as factors of the population’s 
use of health care services (40).  The two main components of health care system are the 
organization and resources, which together form the source of health care services to 
individuals.  The resources of health care system consist of funds and labor, such as 
equipment, materials and medical staff, and the structures in which health care services 
are provided.  Organization is the second dimension, describes the process of controlling 
resources while providing medical services.  Organization consists of access and 
structure.  The access represents the processes through which the patient can get access to 
health care services and obtain treatment. The structure represents characteristics of the 
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health care system responsible for the process after the patient gets access to the health 
care system, such as medical practices of medical professionals, referral process to other 
health care facilities, characteristics of hospital or health care facility, and the delivery of 
health care services after getting admission to health care facility. 
The second component of this model is population characteristics, which describe 
the individual level. It consists of three elements: predisposing factors, need factors and 
enabling factors.  Predisposing factors represent demographic factors, such as gender, age 
and social structure, such as ethnicity, occupation, social network and education. 
Enabling factors represent availability and accessibility of health care services, such as 
income and health insurance.  Need factors represent how people perceive their own 
health in order to seek medical care.  The third component of this model is health 
behaviors, such as exercise diet, self-care and smoking that influence the use of health 
care services and health outcomes.  Finally, the fourth component is the health outcomes 
which represent the dynamic nature of the health care utilization model and the health 
outcomes (perceived health status, patient satisfaction, and health status evaluated by 
medical staff,) affects predisposing, enabling and need factors, in addition to health 
behavior.   
Our thesis focused on the health care system because our purpose is to identify the 
organizational factors that might have an effect on the dose of CR program.   
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Figure (1): Andersen framework for utilization of healthcare(40) 
 
    Conceptual Framework: 
Many factors affecting the dose of CR program, this study highlighted the health 
care system: processes and structure while controlling for population characteristics 
(figure 1).  This study examined the organizational factors of CR and factors related to 
patient that might affect the dose of the CR offered to patients. It investigated the 
following organizational factors: presence of cardiologist on the CR team (yes/no); who 
pays for cardiac rehabilitation (combination / private / public); individual consultation 
with a physician during the program (yes / no); geographical location of CR program 
(rural area or countryside, i.e. a geographic area that is located outside towns and cities, 
or suburban, i.e. a residential district located on the outskirts of a city, or  urban area, i.e. 
larger cities, towns, location of CR within hospital (yes / no); availability of another CR 
program within 20km (yes / no);  CR program offer alternative models of program 
delivery than an on-site program (yes / no); number of  patients in each exercise session; 
and number of staff on the CR team. , the factors related to the patient that might affect 
the dose of CR program include: type of diagnosis, level of risk.  
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Figure (2) conceptual framework for cardiac rehabilitation 
 
Objectives: 
 
The objectives of the study are: 
1. To describe the doses of CR programs at country level, WHO regional level, 
country income classification groups and globally.  
2. To compare doses of CR program offered within the six WHO designated 
regions: African Region, Region of the Americas, South-East Asia Region, 
European Region, Eastern Mediterranean Region, and Western Pacific Region.  
3. To compare the dose of CR program between high income, middle income and 
low income countries. 
4. To identify potential factors that could affect the dose of CR programs worldwide. 
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CHAPTER 4: METHODOLOGY 
Design & Procedure: 
This is a cross sectional study based on secondary data collected using Cardiac 
Rehabilitation Program Questionnaire developed by the International Council of 
Cardiovascular Prevention and Rehabilitation (ICCPR).  
Ethical Consideration: 
The study was approved by Qatar University Institutional Review Board, (IRB: 
QU-IRB 870-E/18). 
Source of Data:  
As per ICCPR team, data were collected from June 2016 to July 2017 through 
REDCap by the ICCPR team using Cardiac Rehabilitation Program Questionnaire. Items 
of the questionnaire were based on previous national CR program surveys. The 
investigative team underwent a process of integration and cleaning of overlapping 
content. The questionnaire was pilot-tested in the Arab world and Canada. It was then 
revised based on responses; i.e. some questions have been slightly revised to improve 
clarity. The final questionnaire was translated to Portuguese, Spanish, and Mandarin. The 
translated questionnaire was reviewed by a national champion with the corresponding 
first language. The translations underwent several review process including back 
translation to English to verify its linguistic validation or accuracy of concepts in the 
translated questionnaire(41).  
  
   
23 
 
Countries where CR services were available were identified first through previous 
reviews and search of: MEDLINE, EMBASE and Google Scholar for articles or abstracts 
on CR. For countries where no CR program was in evidence, the ICCPR team used the 
following strategies: (a) searched for term “cardiac rehabilitation and  country” using 
internet via Google, (b) searched Google for hospitals within these countries, which were 
then searched for CR programs, (c) a snowball sampling strategy was used by the 
International Council of Cardiovascular Prevention and Rehabilitation (ICCPR) members 
and key informants in the field (including European Society of Cardiology national CVD 
prevention coordinators), as well as (d) attended international conferences of relevant 
societies to approach experts in the given countries. Finally, before any country was 
designated as having no CR, international societies (e.g., International Society of 
Physical Medicine and Rehabilitation, European Association of Preventive Cardiology, 
African Heart Network) were contacted to ascertain whether there were any CR programs 
in countries where we lacked confirmation of availability(41).  
 For each country identified to offer CR, first, available CR or cardiac societies 
leadership were contacted to ascertain number of CR programs in their country and to 
facilitate administration of the survey. If there was no society available, senor leaders for 
the CR were identified from the peer-reviewed, or secondly, grey literature / the web. 
Identified leaders were sent an e-mail requesting their assistance administering the survey 
to each program in their country. The identified senior leader at each CR program was 
emailed requesting their completion of the survey. Informed consent was secured through 
an online form(41).  
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To improve response rate, leaders were sent two e-mail reminders at two-week 
interval. The national contact was provided with the response rate after four weeks 
following the initial administration. If the response rate was <40%, they were invited to 
suggest other approaches to improve the  response rate; this often involved personally 
calling programs to ascertain whether they were aware of the survey, and to request 
completion if they had not done so already(41). 
To verify the responses, collected data were cleaned by members of the ICCPR 
before being disseminated to any party. The ICCPR members also checked variables for 
outliers. Where implausible entries were suspected, representatives of relevant countries 
were contacted to verify such suspicious measures(41). 
Target Population: 
The sample consisted of all CR programs identified in countries worldwide  that 
offer services to patients following an acute cardiac event or hospitalization.  
Sample Size: 
Number of CR programs participated=1082 from 93 countries out of the 111 
countries implementing CR programs. 
Measures: 
There are two measures: 
1. Dependent Variable: The dose in minutes that offered by the CR program which is the 
number of sessions of exercise per week multiplied by number of weeks per program 
multiplied by number of minutes per session in each program. 
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2.  The independent variables included both organizational and patient-level variables. 
Factors related to the organization (program) were: presence of cardiologist on the CR 
team (yes/no); who pays for cardiac rehabilitation (combination / private / public); 
individual consultation with a physician during the program (yes / no); geographical 
location of CR program (rural area or countryside, i.e. a geographic area that is located 
outside towns and cities, or suburban, i.e. a residential district located on the outskirts of 
a city, or  urban area, i.e. larger cities, towns, location of CR within hospital (yes / no); 
availability of another CR program within 20km (yes / no);  CR program offer alternative 
models of program delivery than an on-site program (yes / no); number of  patients in 
each exercise session; and number of staff on the CR team. The patient-related factors 
included mainly patient diagnosis accepted in the CR program, i.e. post-myocardial 
infarction/acute coronary syndrome (yes / no), stable coronary artery disease (yes / no), 
post percutaneous coronary intervention (PCI) (yes / no), post coronary artery bypass 
graft surgery (CABG) (yes / no), heart failure (yes / no), heart transplant (yes / no), 
arrhythmias (hemodynamically-stable) (yes / no), cardiomyopathy (yes / no), patients at 
high-risk of cardiovascular disease (primary prevention) (yes / no), level of cardiac risk 
accepted in the CR program (high / moderate / low). 
Data Analysis: 
SPSS 24 were used for data analysis. To achieve the first objective (describe the 
dose at different levels: country level, WHO region level and global level), descriptive 
analysis was carried out, i.e. count, percentage, mean, standard deviation (SD), median, 
and interquartile range (IQR). The mean was used to describe CR dose at country level, 
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and the median was used to describe the dose at regional and global level due to large 
variation among countries within the same region.  
 For the second objective (comparison of dose by the WHO-region and by income 
country group), differences in dose among different WHO regions  and among different 
income groups were examined via, generalized linear model by applying the Generalized 
Estimating Equations (GEE) and pairwise comparison. We conducted GEE to account for 
clustering of countries within WHO regions and within income country groups because 
the within region intra-class correlation coefficient was 0.059, the dose of CR program in 
minutes was the dependent variable and the region was the independent variable. The 
dependent variable (dose of CR program) was continuous positively skewed as shown in 
figure 3, the mean of the dose was 2227.42 minutes and the variance was 10252751.95 
minutes, therefore we used gamma distribution with log link function which is suitable 
for positively skewed outcome.  
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Figure (3) Distribution of the dependent variable (dose of CR program in minutes) 
 
We used the independence working correlation matrix in the GEE analysis the 
quasi-likelihood under independence model criterion (QIC) of the comparison model 
using this correlation matrix was 556.582, which is equal to (QIC) of the same model 
using exchangeable correlation matrix, therefore we used the independence correlation 
matrix to assume that countries  within the same region  are independence.  
To achieve the third objective (factors affecting the dose), we conducted GEE 
procedure to account for clustering of CR programs within countries because the within 
country intraclass correlation coefficient (ICC) indicated clustering issues (ICC= 0.115), 
and we used manual stepwise backward variable selection to find the parsimonious 
model, which kept only significant predictors of the outcome, i.e. dose. QICC was used 
as measure of goodness of fit to choose the best model with significant predictors during 
the manual stepwise backward variable selection procedure, QICC of model was 
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compared with the QICC of the nested model after dropping the non-significant predictor 
one at a time, the model with lower QICC being better fit. In addition to that goodness of 
fit was assessed by the distribution of residual via histogram and scatterplot of Pearson 
residual against the predicted values of the dependent variable (dose of CR program). The 
GEE procedure provides estimates of regression coefficients and their standard errors. 
We reported the multiplicative effect on the mean (MEM) because we used gamma 
distribution with log link function as the dose, dependent variable, was a continuous 
positively skewed variable as shown in figure 3 (42)(43). 
For the model with the significant predictors we used the independence working 
correlation matrix in the GEE analysis, the corrected quasi-likelihood under 
independence model criterion (QICC) of the comparison model using this correlation 
matrix was 437.206, which is equal to (QICC) of the same model using exchangeable 
correlation matrix, therefore we used independence correlation matrix to assume that CR 
programs within the same country are independence.  
The independent variables included both organizational and patient-level 
variables. Factors related to the organization (program) were: presence of cardiologist on 
the CR team (yes/no); who pays for cardiac rehabilitation (combination / private / 
public); individual consultation with a physician during the program (yes / no); 
geographical location of CR program (rural area or countryside, i.e. a geographic area 
that is located outside towns and cities, or suburban, i.e. a residential district located on 
the outskirts of a city, or  urban area, i.e. larger cities, towns, location of CR within 
hospital (yes / no); availability of another CR program within 20km (yes / no);  CR 
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program offer alternative models of program delivery than an on-site program (yes / no); 
number of  patients in each exercise session; and number of staff on the CR team.  
The patient-related factors included mainly patient diagnosis accepted in the CR 
program, i.e. post-myocardial infarction/acute coronary syndrome (yes / no), stable 
coronary artery disease (yes / no), post percutaneous coronary intervention (PCI) (yes / 
no), post coronary artery bypass graft surgery (CABG) (yes / no), heart failure (yes / no), 
heart transplant (yes / no), arrhythmias (hemodynamically-stable) (yes / no), 
cardiomyopathy (yes / no), patients at high-risk of cardiovascular disease (primary 
prevention) (yes / no), level of cardiac risk accepted in the CR program (high / moderate / 
low). 
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CHAPTER 5: RESULTS 
 
Dose Globally and by Country Income Groups: 
 
As shown in Table 1 the global median (interquartile range) duration of CR 
program in terms of minutes was 1440 (interquartile range (IQR) of 1028.7 – 2778.6) 
minutes. As shown in Figure 3, high income countries, the median duration in minutes of 
CR program was 1508.7 (IQR: 1190 -2844.3) minutes  which is higher than that for 
middle income countries 1230 (IQR: 648.5 - 2561.7) minutes per CR program , there 
were no data available for the dose of CR program for low income countries. 
 
 
Figure (3) Median duration of CR program in minutes among country income groups 
In terms of week, the global median of duration of CR programs was 9.2 (IQR: 
6.0-13.8) weeks. As shown in Figure 4, the median number of weeks per CR program in 
high income countries 9.6 (IQR: 7.9 - 13.1) weeks was higher than the median number of 
weeks in middle income countries 7.8 (5.2 - 15.8) weeks which was higher than the 
High-income country
(median)
Middle-income
country (median)
1508.7
1230
Median of duration of CR program in minutes 
among country income groups 
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median number of weeks in low income countries (6 weeks per CR program). Globally, 
24.4% of the countries had a program length of <1000 minutes. 
 
 
Figure (4) Median duration of CR program in weeks among country income groups 
Dose at WHO Regional Level: 
 
Comparing number of minutes per CR program among the six WHO regions the 
median number of minutes per program as shown in Table 1 and Figure 5 was higher for 
Americas 2941 (IQR: 1352.6 -4086.9) minutes , followed by Europe 1440 (IQR: 1042.8 - 
2471.7) minutes  and Eastern Mediterranean 1440 (IQR: 815 -1828.8) minutes ,  then 
Africa 1320 (IQR: 1020 -1620) minutes , followed by Western Pacific 1077 (IQR: 976 -
1200) minutes , then South-East Asia with the shortest 696.7 (IQR: 650 -1293.3) minutes  
per CR program.  
 
High-income
country
(median)
Middle-income
country (median)
Low-income
country (median)
9.6
7.8
6
Median duration of CR program in weeks among 
country income groups
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Figure (5) Median duration of CR program in minutes among WHO regions 
Comparing number of weeks per program among the six WHO regions, as shown 
in Figure 6 the median number of weeks was higher in Americas with 14.1 (IQR: 12-
20.8) weeks followed by Africa 11 (IQR: 8.5-13.5) weeks, Europe 8.9 (IQR: 5.5-10) 
weeks, Eastern Mediterranean 8 (IQR: 6.5-8.9) weeks, Western Pacific 7.9 (IQR: 6.8-12) 
weeks and South-East Asia 6.8 (IQR: 5.8-8.3) weeks. 
 
1320
2941
1440 1440
696.7
1077
Median duration of CR program in  minutes 
among WHO regions 
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Figure (6) Median duration of CR program in weeks among WHO regions 
Dose at Country Level: 
 
  The mean number of minutes per CR program was lowest in Bosnia and 
Herzegovina with 90 minutes per CR program, while Peru had the highest mean number 
of minutes 11073.9 minutes per CR program. Bangladesh had the least program duration 
in weeks, with one week per CR program, while Israel had the largest program duration 
in weeks with 42 weeks per CR program. 
 
 In African regions, two countries participated only; the highest dose of CR 
program among these two countries was in Nigeria with 1920 minutes. In Americas, 21 
countries participated; the highest dose was in Peru with 11073.9 minutes per CR 
program. In Eastern Mediterranean region, 6 countries participated; the highest dose was 
in Tunisia with 2400 minutes per CR program. In Europe, 35 countries participated; the 
11
14.1
8
8.9
6.8
7.9
Median duration of CR program in weeks among 
WHO regions
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highest dose was in Slovenia with 10560 minutes per CR program. In South-East Asia, 
five countries participated; the highest dose was in India with 1535.2 minutes per CR 
program. In Western Pacific region, 9 countries participated; the highest dose was in 
Taiwan with 1577.4 minutes per CR program. 
 
Table 1  
 
Dose of available cardiac rehabilitation program by country, WHO regions and 
country income classification 
 
 
Region 
Country  
 
Income  
Classification 
 
number 
of  
program 
in 
countries 
 
Number 
of  
responses 
 
Average 
Duration 
 in 
Weeks 
 
Total 
Duration in 
Minutes 
 
Rank (1 
is 
greatest) 
 
African (8 countries) 
            
Algeria MIC 1 1 (100%) NA NA NA 
Benin LIC 1 0 NA NA NA 
Kenya MIC 3 1(33.3%) 6 720 65 
Mauritius MIC 1 1 
(100.0%) 
NA NA NA 
Nigeria MIC 1 1 
(100.0%) 
16 1920 28 
South Africa MIC 23 14 
(60.7%) 
NA NA NA 
Tanzania LIC 1 0 NA NA NA 
Uganda LIC 1 0 NA NA NA 
              
Mean ± SD     2.0 ± 5 11 ± 7.1 1320  ± 
848.5 
  
Median (IQR)     1 (0-1) 11 (8.5-
13.5) 
1320 (1020-
1620) 
  
n (%)countries < 1000 
minutes 
1(50.0%)       1(50.0%)   
n (%)countries  
≥12sessions 
1 (50.0%)           
Americas (28 
countries) 
            
Argentina MIC 23 3 (13.0%) 25 8750.0 3 
Aruba HIC 1 0 NA NA NA 
Barbados HIC 1 1 
(100.0%) 
12 2880.0 19 
Bermuda HIC 1 1 
(100.0%) 
24 4320.0 10 
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Table 1 ……continue 
Region 
Country  
 
Income  
Classification 
 
number 
of  
program 
in 
countries 
 
Number 
of  
responses 
 
Average 
Duration 
 in 
Weeks 
 
Total 
Duration in 
Minutes 
 
Rank (1 
is 
greatest) 
Brazil MIC 75 30 
(40.0%) 
20.8 3444.4 14 
Canada HIC 170 57 
(33.5%) 
17.4 3091.6 16 
Chile HIC 10 1 (10.0%) 12 1440.0 37 
Colombia MIC 50 48 
(96.0%) 
14.1 2941.5 17 
Costa Rica MIC 6 6 
(100.0%) 
15 2615.6 21 
Cuba MIC 8 8 
(100.0%) 
20.8 4616.3 8 
Curacao  HIC 2 1 (50.0%) 12 1260.0 47 
Dominican Republic MIC 2 1 (50.0%) 8 1200.0 50 
Ecuador MIC 5 2 (40.0%) 7.5 1603.1 33 
El Salvador MIC 2 0 NA NA NA 
Grenada MIC 1 0 NA NA NA 
Guam HIC 1 0 NA NA NA 
Guatemala MIC 2 2 
(100.0%) 
32 520.0 72 
Honduras MIC 2 1 (50.0%) 5 400.0 74 
Jamaica MIC 3 1 (33.3%) NA NA NA 
Mexico MIC 24 9 (37.5%) 4.3 1352.6 43 
Panama MIC 1 1 
(100.0%) 
8 1260.0 47 
Paraguay MIC 3 3 
(100.0%) 
20 3200.0 15 
Peru MIC 10 7 (70.0%) 20.3 11073.9 1 
Puerto Rico HIC 1 0 NA NA NA 
Trinidad and Tobago HIC 2 0 NA NA NA 
United States of 
America 
HIC 2632 65 (2.5%) 13.7 4086.9 11 
Uruguay HIC 12 5 (41.7%) 28.4 5538.0 5 
Venezuela MIC 9 8 (88.9%) 12.2 2941.1 18 
              
Mean ± SD     9.3 ± 17.8 15.8 ± 
7.6 
3263.0  ± 
2631.4 
  
Median (IQR)     1.5 (1-7.3) 14.1(12-
20.8) 
2941.0 
(1352.6-
4086.9) 
  
n (%)countries < 1000 
minutes 
2 (9.5%)       2 (9.5%)   
n (%)countries  ≥ 12 
sessions 
20 (95.0%)           
Eastern 
Mediterranean  
(12 countries) 
            
Afghanistan LIC 1 1 
(100.0%) 
NA NA NA 
Bahrain HIC 1 1 
(100.0%) 
8 1440.0 37 
Egypt MIC 2 2 
(100.0%) 
NA NA NA 
Iran MIC 34 14 (41%) 9.2 1958.4 27 
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Table 1 ……continue 
Region 
Country  
 
Income  
Classification 
 
number 
of  
program 
in 
countries 
 
Number 
of  
responses 
 
Average 
Duration 
 in 
Weeks 
 
Total 
Duration in 
Minutes 
 
Rank (1 
is 
greatest) 
Lebanon MIC 1 1 
(100.0%) 
20 300.0 75 
Morocco MIC 1 1(100.0%) NA NA NA 
Pakistan MIC 4 2 (50.0%) 6 607.5 69 
Qatar HIC 1 1(100.0%) 8 1440.0 37 
Saudi Arabia HIC 1 0 NA NA NA 
Tunisia MIC 1 1(100.0%) 5 2400.0 24 
United Arab Emirates HIC 1 0 NA NA NA 
              
Mean ± SD     2 ± 3.8 9.4 ± 5.4 1357.6 ± 
792.7 
  
Median (IQR)     1 (0.8-1.3) 8 (6.5-
8.9) 
1440 (815-
1828.8) 
  
n (%)countries < 1000 
minutes 
2 (33.3%)       2 (33.3%)   
n (%)countries  ≥ 12 
sessions 
6 (100%)           
Europe (47 countries)             
Austria HIC 26 5 (19.2%) 9.3 3548.9 13 
Belarus MIC 5 1 (20.0%) 6 648.0 68 
Belgium HIC 48 9 (18.8%) 16 3614.7 12 
Bosnia and 
Herzegovina 
MIC 1 1(100.0%) 2 90.0 78 
Bulgaria MIC 1 1(100.0%) NA NA NA 
Croatia HIC 3 3(100%) 7.5 1603.1 33 
Cyprus HIC 1 0 NA NA NA 
Czech Republic HIC 15 6 (40%) 10 1617.2 31 
Denmark HIC 35 8 (22.9%) 9.6 2520.0 22 
England HIC 266 57 
(21.4%) 
9.9 1609.5 32 
Estonia HIC 2 2(100%) 12 2160.0 26 
Finland HIC 25 11 (44%) 2.5 2250.0 25 
France HIC 130 16 
(12.3%) 
5.5 1803.2 29 
Georgia MIC 17 13 
(76.5%) 
9.3 6881.6 4 
Germany HIC 120 34 
(28.3%) 
5.3 4441.2 9 
Greece HIC 4 4(100%) 15 2423.4 23 
Hungary HIC 33 20 
(60.6%) 
3.5 569.3 70 
Iceland HIC 4 4(100%) 9.6 1160.0 53 
Ireland HIC 37 7 (18.9%) 8.5 1232.5 49 
Israel HIC 22 6 (27.3%) 42 4872.0 7 
Italy HIC 221 70 (31%) 4.8 1296.6 45 
Kazakhstan MIC 1 1(100%) NA NA NA 
Kyrgyz Republic MIC 1 0 NA NA NA 
Latvia HIC 2 1 (50%) NA NA NA 
Lithuania HIC 25 9 (36%) 10 NA NA 
Luxembourg HIC 4 0 NA NA NA 
Malta HIC 1 1(100%) 6 1080.0 55 
Moldova MIC 1 1(100%) NA NA NA 
Montenegro MIC 1 0 NA NA NA 
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Table 1 ……continue 
Region 
Country  
 
Income  
Classification 
 
number 
of  
program 
in 
countries 
 
Number 
of  
responses 
 
Average 
Duration 
 in 
Weeks 
 
Total 
Duration in 
Minutes 
 
Rank (1 
is 
greatest) 
Northern Ireland HIC 13 10 (76.9) 8.4 559.4 71 
Norway HIC 35 0 NA NA NA 
Poland HIC 56 21 
(37.5%) 
3.7 998.5 60 
Portugal HIC 23 21 
(91.3%) 
22.5 5057.0 6 
Romania MIC 3 2 (66.7%) 2 450.0 73 
Russia MIC 3 3(100%) 1.5 225.0 76 
Scotland HIC 69 24 
(34.8%) 
9.5 1035.5 58 
Serbia MIC 2 2(100%) 3 1050.0 57 
Slovak Republic HIC 7 1 (14.3%) 10 1200.0 50 
Slovenia HIC 2 2(100%) 32 10560.0 2 
Spain HIC 87 47 (54%) 9 2832.3 20 
Sweden HIC 69 1 (1.4%) 12 1440.0 37 
Switzerland HIC 51 4 (7.8%) 7.5 1350.0 44 
Turkey MIC 10 9 (90%) 7.6 1353.5 42 
Wales HIC 17 16 
(94.1%) 
8.8 790.2 63 
              
Mean ± SD     10.5  ± 
15.3 
9.9  ±  8 2173.5 ± 
2102.4 
  
Median (IQR)     4 (1-12.5) 8.9 (5.5-
10) 
1440 
(1042.8-
2471.7) 
  
n (%)countries < 1000 
minutes 
8 (22.9%)       8 (22.9%)   
n (%)countries  ≥ 
12sessions 
31 (88.57%)           
South-East Asia (7 
countries) 
            
Bangladesh MIC 1 1(100%) 1 180.0 77 
Dem• Republic of 
Korea 
HIC 17 12 
(70.6%) 
8.6 1293.3 46 
India MIC 23 18 
(78.3%) 
7.5 1535.2 36 
Indonesia MIC 13 10 
(76.9%) 
5.7 696.7 66 
Nepal LIC 1 1(100%) 6 NA NA 
Sri Lanka MIC 4 2 (50%) 20 650.0 67 
Thailand MIC 5 0 NA NA NA 
              
Mean ± SD      6.28 ± 7  8.1 ± 
6.4 
 871 ± 542.3   
Median (IQR)     2 (1-1) 6.75 
(5.8-8.3) 
696.7 (650-
1293.3) 
  
n (%)countries < 1000 
minutes 
3 (60.0%)       3 (60.0%)   
n (%)countries  ≥ 12 
sessions 
5 (83.33%)           
Western Pacific (9 
countries) 
            
Australia HIC 314 85 (27%) 6.8 976.0 61 
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Table 1 ……continue 
Region 
Country  
 
Income  
Classification 
 
number 
of  
program 
in 
countries 
 
Number 
of  
responses 
 
Average 
Duration 
 in 
Weeks 
 
Total 
Duration in 
Minutes 
 
Rank (1 
is 
greatest) 
China MIC 216 83 
(38.4%) 
9.2 1026.4 59 
Japan HIC 325 9 (2.8%) 15 756.3 64 
Malaysia MIC 6 4 (66.7%) 6 1200.0 50 
Mongolia MIC 1 1(100%) NA NA NA 
New Zealand HIC 43 27 
(62.8%) 
7.9 1107.2 54 
Philippines MIC 10 10(100%) 5 951.0 62 
Singapore HIC 7 7(100%) 7 1077.1 56 
Taiwan HIC 35 23 13.1 1577.4 35 
              
Mean ± SD      25.1 ± 
32.2 
 9.1 ± 
3.5 
 1123.5  ± 
252.6 
  
Median  (IQR)     9.5 (4.8-
26) 
7.9 (6.8-
12) 
1077 (976-
1200) 
  
n (%)countries < 1000 
minutes 
3 (33.3%)       3 (33.3%)   
n (%)countries  ≥ 12 
sessions 
9 (100%)           
Global Mean ± SD     9.8 ± 17.3 11.2  ± 
7.6 
2177.7 ± 
2110.1 
  
Global Median  (IQR)     2 (1-9.5) 9.2 (6-
13.8) 
1440 
(1028.7-
2778.6) 
  
High-income country 
mean (median) 
    13.3 (5) 11.8( 
9.6) 
2252.3 
(1508.7) 
  
Middle-income country 
mean (median) 
    6.7 (2) 10.6 
(7.8) 
2081.2 
(1230) 
  
Low-income country 
mean (median) 
    0.4 (0) 6 (6) NA   
Global :n (%)countries 
< 1000 minutes 
19 (24.4%)       19 (24.4%)   
Global: n (%)countries  
≥ 12 sessions 
72 (77.4%)            
 
     NA: not available; SD, standard deviation; IQR, interquartile range 
 
 
 
Pairwise Comparison between the Six WHO Regions: 
 
Using generalized estimating equations procedure and pairwise comparison, 
differences in the mean number of minutes across the six WHO regions was significant 
(P<0.05). As shown in Table 2, the Americas had significantly longer program in terms 
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of minutes than any other regions, Africa had significantly longer program in terms of 
minutes than Western-Pacific and South-East Asia, Europe had significantly longer 
program in term of minutes than Western-Pacific and South-East Asia and finally the 
Eastern Mediterranean region had longer program in terms of minutes than South-East 
Asia. There was no significant difference in means of minutes between Africa and 
Europe, between Africa and Eastern Mediterranean, between Europe and Eastern 
Mediterranean, between Eastern Mediterranean and Western Pacific, and finally between 
Western Pacific and South-East Asia. 
 
 
Table 2 
  
Pairwise comparisons of Dose (minutes) of Available Cardiac Rehabilitation 
programs by the WHO Region 
 
 
WHO region (1) 
 
 WHO region (2) 
 
Mean Difference ±  Std. Error 
(Minutes)¹ 
 
P-
Value² 
 
Africa 
 
Western Pacific 
 
844.21  ± 376.89 
 
0.03 
Africa South-East Asia 1023.23 ± 394.97 0.01 
Americas Africa 1416.54 ± 476.3 0.003 
Americas Europe 1492.42  ±  348.3 < 0.001 
Americas Eastern Mediterranean 1770    ± 417.64 < 0.001 
Americas Western Pacific 2260.75 ±  330.25 < 0.001 
Americas South-East Asia 2439.77 ±  350.75 < 0.001 
Europe Western Pacific 768.33 ± 191.04 < 0.001 
Europe South-East Asia 947.35 ± 224.62 < 0.001 
Eastern Mediterranean South-East Asia 669.76  ±  321.82 < 0.001 
 
   ¹Mean difference = mean WHO region (1) – mean WHO region (2). 
   ² Pairwise comparison using generalized estimating equations procedure. 
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Pairwise Comparison by Country Income Group: 
 
The same generalized estimating equations procedure was used, differences in the 
mean number of minutes between high income country group and middle income country 
group was not significant (P-value: 0.335), as shown in Table 3, middle income country 
group has longer dose of CR program in terms of minutes than the high income country 
group, there is no comparison with low income country group because there were no data 
available for the dose of CR programs in terms of minutes for the low income countries. 
 
Table 3 
 
Pairwise Comparisons of Dose (minutes) of Available Cardiac Rehabilitation 
Programs by Country Income Group 
 
 
Country income  
group 
 
Country income  
group 
 
Mean Difference ± Std. Error (minutes) 
 
P-value 
 
Middle-Income 
 
High-Income 
 
223.2084 ± 231.55098 
 
0.335 
    
 
Factors Associated with Dose of CR Program: 
 
Table 4 presents the factors affecting dose of CR programs. Over three-forth  
(77.8%) of CR programs had cardiologist in the team; 73.8% of program had general 
physician, only 25.3% of the programs were funded by multiple sources, i.e. combination 
of private insurance and government, 12.6% of programs available in rural area, 31.1% of 
CR programs offering alternative models for delivery.  
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Table 4  
 
Characteristics of cardiac rehabilitation programs  
 
 
Factors 
 
Categories 
 
N 
 
Percentage 
 
Presence of Cardiologist in the CR Team 
 
Yes 
 
720 
 
66.5 
  No 206 19.0 
      
Funding source Combination 269 24.9 
  Private 202 18.7 
  Public 592 54.7 
      
Individual consultation with general physician Yes 697 64.4 
 No 248 22.9 
Geographical location of CR program *Rural area 134 12.4 
  Suburban 155 14.3 
  Urban area 775 71.6 
      
 location of CR within Hospital Yes 845 78.1 
  No 205 18.9 
      
Availability of another CR program within 20km Yes 495 45.7 
  No 516 47.7 
      
Diagnosis: Post-Myocardial Infarction/acute 
coronary syndrome 
Yes 833 77.0 
  No 22 2.0 
      
Diagnosis:  Stable coronary artery disease, 
without a recent event or procedure 
Yes 692 64.0 
  No 161 14.9 
      
Diagnosis:  Post percutaneous coronary 
intervention  
Yes 820 75.8 
  No 33 3.0 
      
Diagnosis:  Post coronary artery bypass graft 
surgery (CABG) 
Yes 817 75.5 
  No 36 3.3 
      
Diagnosis:  Heart failure Yes 757 70.0 
  No 96 8.9 
      
Diagnosis:  Heart transplant Yes 470 43.4 
  No 383 35.4 
      
Diagnosis:  Arrhythmias (hemodynamically-
stable) 
Yes 566 52.3 
  No 287 26.5 
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Table 4 ……. continue 
Factors 
 
Categories 
 
N 
 
Percentage 
  No 212 19.6 
      
Diagnosis: Patients at high-risk of cardiovascular  
disease (primary prevention) 
Yes 493 45.6 
  No 360 33.3 
      
level of Cardiac Risk accepted in the CR program high 595 55.0 
  moderate 167 15.4 
  low 22 2.0 
      
CR program offer alternative models of program  
delivery than an on-site program 
Yes 285 26.3 
  No 630 58.2 
      
  N Mean ± SD 
Number of patients in each exercise session  807 9.8 ± 8.3 
      
Number of staff in the CR program   803 2.5 ± 2 
 
      *Rural area or countryside (a geographic area that is located outside towns and cities). 
        Suburban (a residential district located on the outskirts of a city). 
        Urban area (e.g. larger cities, towns). 
 
 
 
 
 
 
 The following organizational factors were significantly associated with dose (P-
value <0.05)  (Table 5): presence of cardiologist on the CR team was significantly 
associated with the dose of CR program with a multiplicative effect on the mean of the 
dose of the CR program (MEM): 1.29 (95% CI: 1.06 to 1.57), i.e., the dose was 29% 
longer in CR programs where the cardiologist is a member of the CR team, compared to 
CR programs where no cardiologist on the CR team. In addition to that CR programs that 
had  general physician who provided individual consultation for  patients had (60%) 
higher dose compared to CR programs which did not offer individual consultation with a 
general physician (MEM: 1.60, 95% CI: 1.35 to 1.91). 
 Further, the dose was significantly higher by 27% (MEM: 1.27, 95% CI: 1.03 to 
1.57) when CR program was funded by a combination of governmental organizations and 
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private health insurance compared to fund from governmental organizations. Funding of 
the CR program by private health insurance only was not significantly associated with 
dose compared to funding by governmental organization alone (MEM: 1.04, 95% CI: 
0.82 to 1.32).  
  Location of CR program was a significant predictor for the dose, CR programs 
located in the rural areas (a geographic area that is located outside towns and cities) had 
35% higher dose compared to CR programs located in the urban areas (e.g. larger cities, 
towns) (MEM:1.35, 95% CI:1.01 to 1.804). Location of CR program in suburban (a 
residential district located on the outskirts of a city) areas was not significantly associated 
with dose compared to urban areas (MEM: 0.97, 95% CI: 0.78 to 1.19). 
  Number of patients per session of CR program was positively associated with 
dose of CR program; increasing the number of patients in each session by one patient is 
associated with 3% increase in the dose of the CR program (MEM: 1.03, (95% CI: 1.01 
to 1.04). Similarly, number of staff in the CR program was positively associated with 
dose of CR program; increasing the number of staff of the CR program by one staff was 
associated with 17% increase in the dose of the CR program (MEM: 1.17, 95% CI: 1.01 
to 1.36). If the CR program offer alternative models of program delivery other than an 
on-site program, it was associated with 17% increase in dose of CR (MEM: 1.17, 95% 
CI: 0.98 to 1.4) but it was not significantly associated with dose; however, it was 
supported by the literature that it increases the adherence to more CR sessions (44). 
 Patients’ factors: The dose of CR program was significantly associated with the 
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following cardiac diseases: Heart Failure, Heart Transplant, and Cardiomyopathy. 
Patients with heart failure had higher dose by 64% compared to patient without heart 
failure (MEM: 1.64, 95% CI: 1.24 to 2.18). Additionally, patients with heart 
transplantation had higher dose of CR program by 22% compared to patient without heart 
transplantation (MEM: 1.22, 95% CI: 1.02 to 1.47). Patients diagnosed with 
cardiomyopathy had higher dose of CR by 38% compared to patient without 
cardiomyopathy (MEM: 1.38, 95% CI: 1.15 to 1.65).  
 The following predictors were not significantly associated with dose of CR 
program (p-value > 0.05): location of CR within hospital, availability of another CR 
program within 20 km, CR program offer alternative models of program  delivery than an 
on-site program, level of cardiac risk accepted in the CR program,  and the following 
diagnosis (post-myocardial infarction/acute coronary syndrome, post coronary artery 
bypass graft surgery, stable coronary artery disease, post percutaneous coronary 
intervention, arrhythmias (hemodynamically-stable), and patients at high-risk of 
cardiovascular  disease.  
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Table 5  
 
CR characteristics associated with dose of cardiac rehabilitation 
programs 
 
 
 
Factors 
 
Categories 
  
MEM٭ 
 
95% Confidence Interval  
 
P-
value 
Lower Upper  
 
Presence of 
Cardiologist in the CR 
Team 
 
Yes 
  
1.29 
 
1.06 
 
1.57 
 
0.013 
  No  1 Reference group  
        
Funding source Combination  1.27 1.03 1.57 0.027 
  Private  1.04 0.82 1.32 0.777 
  Public  1 Reference group  
        
Individual consultation  
with general physician 
Yes  1.6 1.35 1.91 <0.001 
  No  1 Reference group  
        
Geographical location 
of CR program 
Rural area  
 
 1.35 1.01 1.8 0.047 
  Suburban   0.97 0.78 1.19 0.753 
  Urban area  
towns) 
 1 Reference group  
        
Diagnosis:  Heart 
failure 
Yes  1.64 1.24 2.18 0.001 
  No  1 Reference group  
        
Diagnosis:  Heart 
transplant 
Yes  1.22 1.02 1.47 0.03 
  No  1 Reference group  
         
Diagnosis: 
Cardiomyopathy 
Yes  1.38 1.15 1.65 0.001 
  No  1 Reference group  
         
CR program offer 
alternative models of 
program  
delivery than an on-site 
program 
Yes  1.17 0.98 1.4 0.081 
  No  1 Reference group  
         
Number of patients in 
each exercise session 
  1.03 1.01 1.04 <0.001 
         
Number of staff in the 
CR program 
   1.17 1.01 1.36 0.045 
 
٭  MEM: multiplicative effect on the mean 
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The final parsimonious model with significant predictors after backward stepwise 
elimination had the lowest  QICC = 437.206, in addition to that the distribution of 
residuals via histogram and scatter plot of Pearson residuals against the predicted values 
of the outcome were used to assess the goodness of fit of the parsimonious model, as 
shown in the figure 7 the histogram for the residuals showed normal distribution, in 
addition to that the scatterplot of Pearson residuals in figure 8 showed that in general 
there aren’t clear patterns for the distribution of the Pearson residuals which proof that 
the model provide good fit to the data.  
 
 
 
 
Figure 7: distribution of residuals of the parsimonious model with the significant 
predictors 
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Figure 8: Scatterplot of Pearson residuals against the predicted values of the dependent 
variable (dose of CR program) 
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CHAPTER 6: DISCUSSION 
 
 
This is the first study, to the best of our knowledge  that described  dose of CR 
program at global, regional and at country levels.  It is also the first study that compared 
the dose of CR   among the six regions of  the WHO.   Cardiac rehabilitation program 
was available in 111 (54.7%) of the 203 countries in the world (45). Data were collected 
in 93 (83.8%) of these countries with a total of 1082 CR programs completed the survey. 
This represents a response rate of 32.1% of the total 3373 CR programs, worldwide (41). 
The level of missingness was 30.8%, the effective sample size was 749 CR programs. 
Dose of CR Program: 
 
To examine the clinical effectiveness of dose, in the most recent Cochrane 
systematic reviews,  patients who had 1000 or more minutes  had significantly lower  CV 
mortality of 25% and myocardial infarction (MI) of 26% (4). In our study, globally, 
24.4% of the countries had a program length of <1000 minutes. Short CR programs could 
decrease effectiveness of the proram in mortality reduction. (4). Apparantly, countries 
and regions with high burden of CVD and low resources had short CR programs (i.e. less 
than 1000 minutes). Regionally, the South East Asia had the largest proportion of 
countries (60%) with programs less trhan 1000 minutes followed by Africa (50%) , then 
Eastern Mediterranean and Western pacific equally (33.3%). According to the WHO 
report on CVD (46), the deaths from non-communicable diseases have increased in the 
South-East Asia Region, from 6.7 million in 2000 to 8.5 million in 2012. It is also 
estimated that CVD mortality to increase by 2030 with the greatest increase in Africa 
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follwed by the Eastern Mediterranean (46). Further, 13 (38.2%) of MICs had a program 
length of <1000 minutes compared to 10.7% in HICs, while over 80% of CVD deaths 
occur in low-income and middle-income countries) (46). 
High income countries had higher dose of CR in term of minutes with median 
1508.72 (1190 -2844.25) minutes and longer duration, in terms of weeks per CR program 
with median (9.6 (7.9 - 13.1) weeks) compared to low-and middle-income countries. 
In terms of number of sessions provided, a recent systematic review and meta 
analysis suggested that patients with CVD should be prescribed a minimum of 12 
sessions to reduce all-cause mortality (7). However, the length of the session was not 
specified (7). Because of lack of research, we used the 12 sessions per program as the 
baseline value to  explore the effectiveness of CR programs delivered in the present 
study. Globally, 72 (77.42%) of the countries  provided an  average of ≥ 12 sessions per 
CR program; all 9 (100%) ) of the Western Pacific and the  EMR 6 (100%) countries,  20 
(95%) of  the Americas,  31 (88.57%) of the Europe, 5 (83.33%) of the South East Asia 
and 1 (50%) of  the Africa region provided ≥ 12 sessions per CR program. Still, there is 
uncertainity of the effectiveness of CR in terms of number of sessions provided per 
program because  the length of the session varies across programs both in our study and 
the reference study (7).  
Factors Associated with Dose: 
 
 Presence of cardiologist on the CR team had a significant positive association 
with the dose (in terms of minutes) of CR program.  Initially, a patient should have a 
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physician referral to enroll in CR programs (47). Some studies found  positive 
relationship between patient enrollment or complinace to CR programs and  physician 
involvement (48) (49).  
 In addition to patients’ perception of safe environment in the presence of a 
cardiologist in case of adverse affect, Cardiologist could play an inspirational role in 
motivating patients to continue in participating in the CR programs, therfore, more 
demand on service delivered. In fact, frequent motivation by health professionals and 
discussing progress was reported among the most important CR features that encourage 
patients to continue in CR programs (50).  
Within the context of the inspirational and motivational role of physicians, 
providing individual consultation for patients by general physician was positively 
associated with CR dose.  Patients were more likely to participate in CR if their general 
physicians explained CR benefits and motivated them to participate in CR porgram (48). 
 Considering the type of funding of cardiac rehabilitation program, a combination 
of public (government or social security) and private (health insurance, out of pocket 
payment) was a significant positive predictor for the CR dose. This is in line with the 
finding by British Heart Foundation on national CR audit in England, where many groups 
of patients who would benefit are not able to take part because of a lack of funding (51) 
(52).  Other studies (53) (54) found that patient payment is a barrier to CR participation 
and adherence, which could lead to less demand on CR services; consequently, lower 
dose if patient is the one responsible for the payment of CR program, but if the CR 
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program is completely funded by governemnt and private health insurance all patients 
will receive a complete dose of CR program.  
CR programs located in the rural area (a geographic area that is located outside 
towns and cities) offer more dose, this may be explained by the high prevelance of 
cardiac disease and risk factors of cardiac disease i in rural area (55) therfore the 
residents of these areas need more dose of CR program to reduce risk factors of cardiac 
disease and improve cardiac function. 
Number of patients in each session of CR program and number of staff in the CR 
program had a significant positive association with the dose of CR program. CR 
programs usually accept more patients if they are resourceful, i.e. they have the capacity 
to offer higher dose, e.g. more sessions per program, due to availability of resources, such 
as space, equipment, and staff. With more number of staff, programs can offer more 
sessions per program and some programs could offer after work (evening) and during 
weekends sessions. Adequate resources, including number of staff, space and equipment 
were found to increase the  adherence to CR program in one study, therefore patients 
received more sessions of CR program (49). On the other hand, in a qualitative study,  
lack of equipment and inadequate physical space have been identified as barriers to CR 
enrollment (56).  
CR programs offer alternative model of delivery was not significantly associated 
with dose. A study showed that CR alternative model for delivery, i.e. home based 
increased the adherence to more sessions, especially for those with travel or cost barriers 
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if they want to attend the supervised program (44). 
The dose of CR program was possitively associated with the following cardiac 
diseases: heart failure, heart transplant, and cardiomyopathy, these findings may be 
expalined by the severity of disease.  Patients with severe diagnosis as the 
aforementioned diagnosis need longer CR duration, i.e more sessions, in USA, those 
patients are covered up to 72 sessions (57).  
Limitations: 
 
Our study has few limitations. First, the study based on secondary data and it has 
missing values. Imputation of missing data could assist in reducing this effect but it is out 
of the timeline of this study. Second, limitation on generalizability particularly due to 
possibility of self-selection bias and the low response rates within countries. The ICCPR 
Global Team documented that there were difficulties in identifying programs in LMIC 
(45). Respondents may have been inclined to respond in a socially desirable manner to 
reflect better provision of CR services in their programs or country. However, this 
limitation can be mitigated if the non-respondent programs were shown to be not 
significantly different from the participating programs on characteristics that affect the 
dose. However, we did not have access to non-respondents’ information and we have 
time limit to reach out. Finally, the dose could be overestimated because most probably, 
those participated in the survey could be large resourceful programs. For example, some 
poor regions or countries, specifically Africa could not be well presented may be due to 
lack of resources. 
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Significance: 
 
This is the first study to characterize dose globally. Cardiac rehabilitation program 
is a secondary prevention program, help the patient to recover and return to practice his 
daily life activities, although the evidence that the dose of cardiac rehabilitation program 
is very important to achieve the desired outcome for cardiac patient of improving their 
health and prevent subsequent cardiac complications, there is lack of research regarding 
the organizational factors that could affect the dose of cardiac rehabilitation, therefore, 
this is the first empirical study that described and characterized the dose of  CR programs 
at country, WHO designated six regions, country income classification, and global levels, 
and this is first study examined the organizational factors and patient related factors that 
could affect the dose. Our results are expected to guide policy makers of CR programs in 
identifying gaps in CR dose to improve their programs to achieve the desired outcome 
and reduce the cost of CVD. 
Strength: 
 
The study uses global data from more than 90 countries and more than 1000 
programs worldwide, and it is the first ever global study described and characterized dose 
of CR program at country, WHO region, country income classification, and global levels, 
and determined the significant factors that could affect dose of the CR program. 
Conclusion:  
 
In conclusion, despite guideline recommendations that CVD patients should 
access CR, it is only available in 111 (54.7%) countries around the world. Advocacy for 
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more programs, that each serve the maximal number of patients safely, is needed to 
ensure all indicated patients achieve the reductions in mortality and morbidity associated 
with CR participation.  
The findings of this study have important implications for the directors of CR 
program; organizational factors influence the dose of CR program.  Some modifiable 
organizational factors were identified including presence of cardiologist and general 
physician on the CR team, funding the CR program by a combination of governmental 
organizations and private health insurance, increase number of staff in the CR program, 
and offering alternative models of program delivery than an on-site, each of which may 
guide decision-makers improve the dose of CR programs to achieve reductions in both 
mortality and morbidity associated with cardiovascular diseases. The study recommends  
financial support of CR programs through multiple sources to encourage patients to 
uptake more CR doses, increase number of CR programs in rural areas and to provide 
alternative models for delivery than onsite like home-based, especially for patients who 
have difficulty to participate in CR programs due to distance or funding reasons. 
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APPENDIX 
 
 
CARDIAC REHABILITATION PROGRAM QUESTIONNAIRE  
 
Instructions: Please answer the series of questions by: (1) checking () the appropriate 
box (sometimes one box and other times you will be asked to check as many boxes as 
apply), (2) typing in an answer, or (3) entering a number, as indicated. The survey items 
for which you enter numbers are constrained to one value (i.e., you cannot enter a range. 
If you would like to enter a range, instead enter the midpoint) and will not accept text. 
You can report a number to up to 1 decimal place if desired. Enter zero (0) only if the 
answer is none.  
Be sure to click the “Submit” button when you reach the end of the survey.  
1. What is your Title/Position at the cardiac rehabilitation program? (check one): 
 Director 
 Coordinator / Manager / Supervisor 
 Clinician  
Please specify__________________________________________________ 
 Other 
Please specify __________________________________________________ 
Section A: General information  
2. In what country is your cardiac rehabilitation program? ______________ 
2.b. Please, specify your country________________________________________ 
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3. City / Region: ___________________(optional) 
4. Your cardiac rehabilitation program is located in an/a: 
 Urban area (e.g.larger cities, towns) 
 Suburban (a residential district located on the outskirts of a city) 
 Rural area or countryside (a geographic area that is located outside towns 
and cities). 
5. In what year was your cardiac rehabilitation program initiated? Please enter a valid 
four digit start year      _______ (year) 
6. Who pays for cardiac rehabilitation? (Check all that apply)  
 Social security / government 
 Hospital or clinical center where the cardiac rehab service is based  
 Patient         
 Private health insurance  
 Other  
Please specify ____________________________________________________  
6.b. What is the average percent of the total program cost that patients pay, if they 
complete the program? (Please enter a numeric value only in the field) _____ %  
       6.c. What is the direct cost to patients to participate, if they complete the 
program?  (Note: Please enter amount. Enter a numeric value) _____________ Amount 
    6.c2. Please specify currency _________________ Currency. 
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7. Is your cardiac rehabilitation program located within a hospital?  
 Yes – it is in a referral / quarternary / tertiary facility and / or academic center 
 Yes – it is in a community hospital 
 Yes -  it is in a rehabilitation hospital/ residential facility  
 Yes – other  
     Please specify where your cardiac rehabilitation is located __________ 
 No (skip to question 10) 
     7b. Is your Phase II program a spa / residential? 
 Yes  
 No 
8. If Q7 was marked yes, does the hospital have an inpatient cardiology service?  
(Check one box):  
 Yes, and these patients are referred to our cardiac rehabilitation program 
regularly 
 Yes, and these patients are sometimes referred to our cardiac rehabilitation 
program 
 Yes, and these patients are rarely referred to our cardiac rehabilitation 
program  
 No    
9. If Q7 and Q8 were marked yes, do they offer? (check all that apply) 
 Revascularization via percutaneous coronary intervention (PCI)  
 Coronary artery bypass graft surgery (CABG)  
 Percutaneous valve implantation 
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 Implantable heart devices (pacemakers or defibrillators) 
 Cardiac transplant 
 None 
10. In what department is the cardiac rehabilitation program situated administratively? 
 Cardiology department 
 Physical Medicine and Rehabilitation department 
 Internal Medicine department 
 Primary / general practice 
 It is in a community facility 
 None – it is stand-alone 
 Other  
Please specify____________________________________________ 
11. For patients referred following a cardiac hospitalization, on average how many 
weeks after discharge does a patient start your program? (i.e., initial assessment 
appointment) (Please enter a numeric value in the field __________ weeks 
12. How many unique cardiac rehabilitation patients do you provide service to each 
year in your program? (Please enter a numeric value) ______ patients per year  
13. How many patients do you have capacity to serve each year, in terms of staff and 
space? (Please enter a numeric value)_____________ patients per year   
14. What is the cost to your program to serve one (1) patient, if they complete the 
program? (Note: Please specify amount. Enter a numeric value in the field) 
           ______________________  Amount    
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     14.b. Please specify currency ________________________ Currency 
15. Who can refer a patient to your program? (Check all that apply) 
 Patients can self-refer 
 Physicians 
 Allied healthcare providers and / or nurses 
 Community health care workers 
 Other 
Please specify ___________________________________ 
16. Are there any other Cardiac Rehabilitation programs in your area? (Check only 
one box) 
 Yes, within approximately a 20 km radius 
 Yes, but more than 20 km away 
 None  
 I don’t know 
 
17. Please rate the degree to which each of the following are barriers to greater patient 
participation in your cardiac rehab program, from “this is definitely not an issue” 
to “this is a major issue”: Check one per row. 
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Lack of patient referral      
 
Lack of equipment        
 
Lack of space      
 
Lack of human resources      
 
Lack of financial resources/ 
budget 
     
 
Other barrier  
 
     
Please specify the equipment you lack, if applicable______________________ 
Please specify the other barrier, if applicable ___________________________ 
 
This is  
definitely not    
an issue 
 
This is  
 Not  
an  
issue 
 
Neutral 
 
This is  
a minor  
issue 
 
This is  
major  
issue 
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SECTION B: DETAILS ABOUT YOUR CARDIAC REHABILITATION PROGRAM 
18. Who has overall responsibility for cardiac rehabilitation at your program? (Please 
check one box)  
 Cardiologist 
 Physician specialist in internal medicine 
 Physical medicine and rehabilitation (physiatrist) 
 Physician, other specialty  
 If you selected "Physician, other specialty", please specify the specialty here 
________________ 
 Nurse 
 Exercise physiologist 
 Physiotherapist  
 Other  
 If you checked "other", please specify the heath profession here 
_________________________ 
19. How expensive are the following aspects of delivering your cardiac rehab 
program? (check one box per row) 
 
 Free Only a 
minor 
cost 
Costs 
a bit 
Costs 
quite 
a bit 
Very 
expensive 
Not 
applicable 
as we do 
not have 
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this 
Front-line personnel             
Space             
Exercise equipment             
Equipment / supplies for 
cardiovascular risk 
assessment (not including 
exercise stress tests) 
            
Exercise stress testing on 
a treadmill or cycle 
ergometer 
            
Patient education 
materials 
            
Blood pressure 
assessment device 
            
Blood collection and lipid 
testing 
            
Free weights etc. for 
resistance training 
            
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20. Which of the following components of cardiac rehabilitation are provided in your 
program? If they are provided, are they provided in all the models you deliver? 
(i.e., supervised and home-based programs)?  
Please check one box per row. If you only offer one model of rehabilitation and you 
offer the listed component, please check “yes, in all models”.  
 
 Yes  
In  
all models 
Yes 
For    
some models 
No 
Initial assessment       
Individual consultation with a physician       
Individual consultation with a nurse       
Exercise stress test       
Other functional capacity test        
Assessment of strength (e.g., handgrip)        
Assessment for comorbities / issues that 
could impact exercise (e.g., cognition, 
vision, musculoskeletal / mobility 
issues, frailty, and / or balance / falls 
risk) 
      
Exercise prescription       
Physical activity counseling       
  
   
75 
 
Supervised exercise training       
Heart rate measurement training for 
patients  
      
Resistance training        
Management of cardiovascular risk 
factors 
      
Prescription and/or titration of 
secondary prevention medications 
      
Nutrition counseling       
Depression screening       
Psychological counseling        
Smoking cessation sessions/classes       
Vocational counseling / support for 
return-to-work 
      
Stress management / Relaxation 
techniques 
      
Alternative forms of exercise, such as 
yoga, dance, or tai chi  
      
Women-only classes       
End of program re-assessment       
Electronic patient charting       
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Communication of patient assessment 
results with their primary care provider                                         
      
Follow-up after oupatient program       
Other        
 If applicable, please specify what other functional capacity test is used in your program 
________________________________ 
If applicable, please specify what other alternative forms of exercise are offered in your 
program ________________________________ 
If applicable, please specify what components of cardiac rehabilitation are provided in 
your program ________________________________ 
 
21. How many education sessions are provided to each patient in your program? 
(Please enter a numeric value) _____ sessions   
22. How many minutes on average is each education session? (Please enter a numeric 
value)______ minutes   
23. In your program, do you assess the following risk factors? Please check one box 
per row.  
 Yes No 
Time spent being sedentary     
Tobacco use     
Harmful use of alcohol     
Blood pressure     
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Body mass Index     
Waist circumference     
Hip circumference     
Body composition     
Total Cholesterol     
Cholesterol fractions (HDL-c, LDL-c)     
Triglycerides     
HbA1c for diabetic patients     
Blood glucose for non-diabetic patients     
Sleep apnea     
Depression / Anxiety     
Physical inactivity     
Poor diet     
Other factor(s)     
 
Please specify which other factor(s) you assess in your program 
24. Which types of personnel are part of your cardiovascular rehabilitation (CR) team? 
If they are part of your team, do they work in Cardiac Rehabilitation only, or do 
they have other department obligations? (Check one box in each row):  
 
 Yes-Only 
CR 
Yes-Partial No 
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Cardiologist                          
    
      
Physiatrist (Physical Medicine and 
Rehabilitation) 
      
Sports Medicine Physician            
    
      
Other Physician        
 
Physiotherapist                      
        
      
Nurse    
    
      
Nurse practitioner        
    
      
Psychiatrist                          
        
      
Psychologist                         
        
      
Social worker         
    
      
Dietitian                      
        
      
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Kinesiologist   
    
      
Pharmacist   
    
      
Exercise specialist  
    
      
Community Health worker 
    
      
Administrative assistant/ Secretary
    
      
Other         
 
 Please specify what kind of other physician __________________________________ 
Please specify which other type of personnel are part of your team 
_______________________  
25. Do all your clinical staff supervising patients during exercise sessions have 
cardiopulmonary resuscitation (CPR) training / certification? 
 Yes  
 No (skip to question 26) 
25b. If yes, are they required to renew their CPR training regularly? 
 Yes 
 No 
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25c. If yes, is the CPR certification advanced or basic? (check one box per row) 
 Advanced CPR training Basic CPR training 
Physicians     
Nurses     
Other     
 
26. Does your program have each of the following ítems, and if yes, is its’ use 
dedicated to your program or shared with another group (check one option in each 
row)?  
 
 DEDICATED SHARED NOT 
AVAILABLE 
BICYCLE ERGOMETER         
TREADMILL ERGOMETER 
   
    
 
  
ARM 
CYCLOERGOMENTER  
      
DOPPLER 
ECHOCARDIOGRAPHY   
      
STRESS TEST (NO O2) 
   
      
STRESS TEST WITH O2       
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TELEMETRY   
   
      
GROUP EDUCATION 
ROOM    
      
GYM SPACE   
  
      
INDIVIDUAL 
ASSESSMENT/ 
COUNSELLING ROOM 
  
      
PATIENT CHANGE ROOM 
  
      
ADMINISTRATIVE OFFICE
   
      
ELECTRONIC PATIENT 
CHARTS   
      
RESISTANCE TRAINING 
EQUIPMENT  
      
BODY COMPOSITION 
ANALYZER   
      
STAFF MEETING ROOM       
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STAFF OFFICE SPACE 
   
      
OTHER           
 
 Please specify what other items your program has __________________________ 
27. Does your site offer a supervised Cardiac Rehabilitation program? 
  
 Yes   
 No  
SECTION C: CARDIAC REHABILITATION – Supervised Program 
28. Which of the following cardiac diagnoses or indications do you accept for your 
supervised program? (Check all that apply)  
 Post Myocardial Infarction / acute coronary syndrome   
 Stable coronary artery disease, without a recent event or procedure          
 Post percutaneous coronary intervention (PCI)   
 Post coronary artery bypass graft surgery (CABG)  
 Heart failure    
 Patients who have had valve surgery/repair or transcatheter aortic valve 
implantation (TAVI)  
 Heart transplant  
 Patients with ventricular assist devices 
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 Arrhythmias (hemodynamically-stable) 
 Patients with implanted devices for rhythm control  (i.e., ICD / CRT, pacemaker)           
 Congenital heart disease 
 Cardiomyopathy 
 Rheumatic heart disease   
 Patients at high-risk of cardiovascular disease (primary prevention) 
 Non-cardiac chronic diseases 
 Other 
Please specify ____________________ 
29. Which of the following non-cardiac diagnoses or indications do you accept for 
your on-site program? (Check all that apply)   
 Stroke 
 Intermittent claudication / peripheral vascular disease 
 Cancer 
 Diabetes 
 Chronic lung disease 
 None 
 Other  
 Please, specify which other non-cardiac diagnosis is accepted in your 
program_______________ 
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30. Which of the following patient levels of cardiac risk do you accept for your 
supervised program?  (Check all that apply) 
 Low 
 Moderate 
 High 
 Not applicable because we do not risk stratify at our program 
 
31. Do patients have an individual consult with a physician during the program?  
 Yes  
 No 
31b. If yes, Please specify the number of times in a full program the patients have 
an individual consult with a physician (Please enter a numeric value) ______ times 
32. What is the standard duration of the on-site cardiac rehabilitation program that you 
provide to patients? (Please enter a numeric value.) __________ weeks  
33. On average, for how many sessions does each patient come on-site each week? 
(i.e., frequency; Note: if you run a residential program, leave this question blank 
and instead answer the next question; do not report how many sessions your 
program runs in a week) __________ sessions per week  
    33b. At your spa/residential program: On average, how many CR sessions do offer 
patients each day? (Please enter a numeric value in the field.) _____ sessions / day 
(residential programs) 
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34. On average, how many patients are in each exercise session? (Please enter a 
numeric value) __________ patients / session  
35. On average, how long is each exercise session (including warm up, aerobic 
exercise, strength training and/ or cool down)? (Please enter a numeric value) 
_____________ minutes / session 
36. What is the maximum number of patients that your program allows in the same 
exercise session? (Please enter a numeric value in the field.)_____ patients / 
session 
37. What is the staff to patient ratio during supervised exercise at your program? 
(Note: if there are 6 staff persons per 14 patients, enter 6 in the first box and 14 in 
the second box) (Please enter a numeric value in the fields.)   
37b. Insert here the staff number in the staff-to-patient ratio: ______ 
        37c. Insert here the patient number in the staff-to-patient ratio: ______ 
38. Which healthcare professionals are usually present during exercise sessions? 
(Check one box in each row)  
    Present Not  
usually  
present 
Cardiologist      
Physiatrist (Physical Medicine and 
Rehabilitation)  
    
Sports Medicine Physician                  
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Other Physician       
Physiotherapist                                  
Nurse      
   
    
Nurse practitioner          
   
    
Psychiatrist                                
   
    
Psychologist                               
   
    
Social worker           
   
    
Dietitian                            
   
    
Kinesiologist     
   
    
Pharmacist     
   
    
Exercise specialist    
   
    
Community health worker       
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Other     
Please specify which other physician is usually present during exercise 
sessions________________________________  
Please specify which other healthcare professionals are usually present during exercise 
sessions_________________________________ 
39. Does the supervised program offer telemetry or another method of monitoring 
patients’ clinical status while exercising? (check all that apply) 
 Yes, telemetry 
 Yes, other method of monitoring 
 None 
  If other method of monitoring please specify:  
 Borg scale (perceived exertion) 
 Heart rate 
 Other 
 If applicable, please specify what other method of monitoring is used in your 
program____________________________ 
SECTION D- ALTERNATIVE MODELS OF CARDIAC REHABILITATION DELIVERY  
40. Are alternative cardiac rehabilitation models such as home-based, reimbursable by 
government or insurance companies in your region?  
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 Yes 
 Please specify which model are reimbursable by government or insurance 
companies_____________________ 
 No 
41. Does your cardiac rehabilitation program offer alternative models of program 
delivery than an on-site program?  
 Yes 
 No  
41b. If Q41 was marked: yes, please specify (check all that apply):  
 Home-based (includes web or Smartphone-based) 
 Community-based  
 Hybrid of supervised with home or community-based  
 Please describe the nature of your hybrid 
model________________________ 
 Other 
 Please, specify what other alternative model is 
offered___________________ 
 
If Q41b was marked: home–based program, please answer the following questions:  
42. When did the home-based program start? (Please enter a numeric value) 
____________ year 
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43. What percentage of your patients are served in a home-based program? (Enter 
‘unknown’ if you do not know) (Please enter a numeric value)_______ % 
44. Do you perceive your program has sufficient capacity to meet need/demand in the 
home-based model?  
 Yes 
 No 
44b. If NO, please specify why your program doesn't have sufficient capacity to 
meet/demand in the home-based model (check all that apply): 
 Not enough funding 
 Not enough staff 
 Not enough other resources 
 Patients’ risk too high for unsupervised exercise 
 Other 
Please specify the other reason your program doesn't have sufficient 
capacity in the home-based 
program__________________________________________ 
 
45. What is the standard duration of the home-based cardiac rehabilitation program 
that you provide to patients? (specify in weeks) (Please enter a numeric value in 
the field)_______ weeks 
46. On average, how many sessions (i.e., formal contact with the Cardiac 
Rehabilitation staff) does each patient complete in the home-based program each 
  
   
90 
 
month? (frequency; do not report how many sessions your program runs in a 
month for all home-based patients)____ sessions / month 
 
47. On what basis are patients offered a home-based program? (check all that apply) 
 Risk stratification 
 Patient indication 
 Distance to centre 
 Time or work constraints during the Cardiac Rehabilitation centre hours 
 Transportation barriers 
 Patient choice 
 Cost 
 Other 
Please, specify on what other basis are patients offered a home-based 
program_________ 
48. Does the home-based program offer telemetry or another method of monitoring 
patients’ clinical status while exercising? (check all that apply) 
 Yes telemetry 
 Yes other method of monitoring 
 None 
 If other method of monitoring please specify:  
 Borg scale (perceived exertion) 
 Heart rate 
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 Other 
Please specify what other method of monitoring is used in your 
program____________________________ 
49. Do participants in your home-based program receive any materials to support them 
in the program? (check all that apply) 
 Yes they receive an activity tracker (e.g., pedometer, accelerometer, log book) 
 Yes they receive resistance training materials (e.g., therabands, dumbbells) 
 Yes they receive education materials (e.g., workbook) 
 Yes they receive other materials  
 Please specify what other materials they 
receive_______________________________ 
 Sometimes  
 Please describe under what instances participants receive materials, and type 
of material(s) provided__________________________________________ 
 No 
50. Which of the following patient levels of cardiac risk do you accept for your home-
based program?  (Check all that apply) 
 Low 
 Moderate 
 High 
 Not applicable because we do not risk stratify at our program 
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51. What forms of communication are used with patients in your home-based 
program? (check one box per row, to report the frequency) 
 
 Never Daily Several 
Times/week 
Weekly Several 
times / 
month 
Monthly Just 
once 
Internet 
webpage 
              
Email               
Webcam               
Mobile 
phone 
              
Smartphone 
app 
              
Text 
messages 
              
Log or 
diary 
(paper) 
              
Telephone 
(landline) 
              
In-person /               
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on-site visit 
Other                
 
Please specify what other form of communication is used in your home-based 
program____________________________ 
52. Did you perceive any barriers to using these communication tools?  
 Yes 
 No 
       Check all the barriers that apply: 
 Logistical problems: i.e., connection 
 Lack of patient access (i.e., patients do not have computer 
with email) 
 Difficulty for the clinical staff  
Please specify the difficulties for the clinical 
staff_____________________ 
 Difficulty for the patients  
Please specify the difficulties for the 
patients_________________________ 
 Other  
Please specify other perceived barriers to communicating 
with patients via 
technology_______________________________________
___________ 
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53. Which providers interact directly with the patients in the home-based cardiac 
rehabilitation program? Please check all that apply:  
 Physician 
 Please specify the specialty of the physician who interacts directly with 
the patients in the home-based program 
_________________________________  
 Nurse 
 Exercise physiologist 
 Physiotherapist  
 Other 
Please specify who interacts with the patient in the home-based 
program____________________________________________ 
 
54.  What do you think you would need to be ready and able to significantly increase 
your program’s capacity to provide home-based cardiac rehabilitation services to 
patients?  
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_______________________________________ 
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If Q41b was marked: Community-based program, please answer the following:  
55. Where does the community-based program take place? 
 Public center 
 Private center  
 Semi-private center 
 Other 
Please specify where the community-based program takes 
place_______________________ 
56. When did it start? (Please enter a numeric value) 
             _______ year  
57. What proportion of your patients are served in the community-based program? 
(Please, enter a percentage; only a number) ______ % 
58. On average, how many patients are in each exercise session? (Please enter a 
numeric value)__________ patients / session  
59. How many classes do you offer in a week? (for all patients)______ sessions per 
week 
    60. Which of the following patient levels of cardiac risk do you accept for your     
community-based program?  (Check all that apply) 
 Low 
 Moderate 
 High 
 Not applicable because we do not risk stratify at our program 
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61. Which type of provider is most responsible to supervise the Community-based 
exercise sessions? Please check one box:  
 Physician type 
Please specify the specialty ______________________________ 
 Nurse 
 Exercise physiologist 
 Physiotherapist  
 Other 
Please specify who is the most responsible to supervise the community-
based program_______________________________________________ 
62. What is the standard duration of the community-based cardiac rehabilitation program 
that you provide to patients? (Please enter a numeric value) 
__________ weeks  
63. On average, how many sessions does each patient complete in the community-based 
program each month? (i.e., frequency; do not report how many sessions your program 
runs in a month)__________ sessions per month 
64. On what basis are patients offered a community-based program? (check all that 
apply) 
 Risk stratification 
 Patient indication 
 Distance to main Cardiac Rehabilitation centre 
 Time or work constraints during the Cardiac Rehabilitation centre hours 
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 Transportation barriers 
 Patient choice 
 Cost 
 We do not have a main centre in a clinical setting 
 Other 
Please specify on what other basis patients are offered a community-based 
program_______________________________________________ 
65. Does the community-based program offer telemetry or another method of 
monitoring patients’ clinical status while exercising? (check all that apply) 
 Yes, telemetry 
 Yes, other method of monitoring  
 None 
65.b. Please specify what other method of monitoring is used in your community-based 
program 
 Borg scale (perceived exertion) 
 Heart rate 
 Other 
Please specify what other method of monitoring is 
used______________ 
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66. What do you think you would need to be ready and able to significantly increase 
your program’s capacity to provide community-based cardiac rehabilitation services to 
patients?  
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
______________________________ 
Thank you most sincerely on behalf of the International Council of Cardiovascular 
Prevention and Rehabilitation for the time and expertise you have committed to complete 
this important questionnaire.  
In return for your participation, we would like to offer you some information describing 
the nature of cardiac rehabilitation as delivered in your country / region. This may be 
useful to your program.  
Please note, we will not have the opportunity to compile this information and share it 
with you until we have finished collecting data from as many programs as possible. 
 
If you would like to receive this information via email, please check this box 
 Yes, I would like to receive information describing the nature of cardiac rehab 
delivered in my country / region 
 
 
 
 
